Find out how an experienced industry CEO teamed up with a UCSF faculty member to start a company focused on an innovative approach to Alzheimer’s disease therapy. Casey Lynch, co-founder and CEO of Cortexyme, will describe the path from unfunded startup idea to two successful venture capital financings. Cortexyme has raised a total of $100M since 2014.
Wednesday, September 26, 2018 at 5:15pm to 7:30pm
Genentech Hall, N114
600 16th St, San Francisco, CA 94158